Funds innovative research on recurrent respiratory papillomatosis (RRP), supporting studies on its prevention, diagnosis, treatment, and underlying mechanisms.
Funder: American Academy of Otolaryngology - Head and Neck Surgery
Due Dates (Anticipated): October 2026 (ASPO annual meeting abstract) | December 2026 (Letter of Intent) | January 2027 (Full application)
Funding Amounts: $10,000 total for up to 12 months; non-renewable but a one-year no-cost extension may be requested. Indirect costs capped at 10% of direct costs.
Summary: Funds innovative research on recurrent respiratory papillomatosis (RRP), including prevention, diagnosis, treatment, and disease mechanisms.
Key Information: Forecasted dates—check program page for updates. No PI salary or travel expenses allowed; indirect costs limited.
This grant supports basic, translational, or clinical research projects focused on recurrent respiratory papillomatosis (RRP). Eligible projects can address the prevention, diagnosis, treatment, outcomes, or pathophysiology of RRP. Proposals introducing new methodologies from other disciplines or demonstrating collaborative efforts are encouraged. The funding aims to foster innovative research that can be completed within the award period and has potential to evolve into long-term or expanded research programs. Institutional support, regulatory approvals (IRB/IACUC), and regular progress/final reports are required.